Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))

Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gomez-Escobar, Lunkun Ma, Ankit Gilani, Sergio Alvarez-Mulett, Evan T. Sholle, Vasuretha Chandar, Yaron Bram, Katherine Hoffman, Priya Bhardwaj, Phoebe Piloco, Alfonso Rubio-Navarro, Skyler Uhl, Lucia Carrau, Sean Houhgton, David Redmond, Alpana P. ShuklaParag Goyal, Kristy A. Brown, Benjamin R. tenOever, Laura C. Alonso, Robert E. Schwartz, Edward J. Schenck, Monika M. Safford, James C. Lo

Research output: Contribution to journalComment/debate

20 Scopus citations

Abstract

(Cell Metabolism 33, 2174–2188.e1–e5, November 2, 2021) It was brought to the authors’ attention by readers that ARDS was not adequately defined. The STAR Methods have now been updated with specific clinical (ventilatory and oxygenation) parameters used to qualify for ARDS along with accompanying references.

Original languageEnglish
Pages (from-to)2484
Number of pages1
JournalCell Metabolism
Volume33
Issue number12
DOIs
StatePublished - 7 Dec 2021

Fingerprint

Dive into the research topics of 'Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))'. Together they form a unique fingerprint.

Cite this